| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| CBR | carbonyl reductase; chemical, biological, and radiological [warfare]; chemically-bound residue; chro... |
| CCCP | carbonyl cyanide m-chloro-phenyl-hydrazone |
| CSA | Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen... |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| CDI | 1,1'-carbonyl-diimidazole |
|---|---|
| CCCP | Carbonyl cyanide m-chloro-phenylhydrazone |
| CR | Carbonyl reductase |
| COS | Carbonyl sulfide |
| FCCP | of carbonyl cyanide p-trifluoromethoxy-phenylhydrazone |
naso-oral
| carbonyl | The characteristic group, -CO-, of the ketones, aldehydes, and organic acids. (05 Mar 2000) |
|---|---|
| carbonyl cyanide m-chlorophenyl hydrazone | <chemical> A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes. Pharmacological action: uncoupling agents, ionophores. Chemical name: Propanedinitrile, ((3-chlorophenyl)hydrazono)- (12 Dec 1998) |
| carbonyl cyanide p-trifluoromethoxyphenylhydrazone | <chemical> A proton ionophore that is commonly used as an uncoupling agent in biochemical studies. Pharmacological action: ionophores, uncoupling agents. Chemical name: Propanedinitrile, ((4-(trifluoromethoxy)phenyl)hydrazono)- (12 Dec 1998) |
| carbonyl group | A group in which an oxygen atom is double-bonded to a carbon atom: O=C. The carbon atom then has two additional bonds to attach to the rest of the molecule. Organic molecules containing a carbonyl group are a very important, major group of compounds studied in the field of organic chemistry. (09 Oct 1997) |
| pig lung carbonyl reductase | <enzyme> Tetrameric carbonyl reductase; mw 24 kD; properties distinct from monomeric cr; it is mainly distributed in the mitochondria of the pig lung; exhibits very low substrate specificity for aromatic and aliphatic carbonyl compounds and catalyses the oxidation of secondary alcohols and aldehydes; activated 2-5 fold by fatty acids ddbj/embl/genbank d16511 Registry number: EC 1.1.1.- (26 Jun 1999) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| cancer, oral | Cancer of the mouth area. A sore in the mouth that does not heal can be a warning sign of oral cancer. A biopsy is the only to know whether as abnormal area in the oral cavity is cancer. Oral cancer is caused by tobacco (smoking and chewing) and alcohol use. Surgery to remove the tumour in the mouth is the usual treatment for patients with oral cancer. (12 Dec 1998) |
| candidiasis, oral | Infection of the mucous membranes of the mouth by a fungus of the genus candida. (12 Dec 1998) |
| canine oral papilloma | Warts affecting mucous membranes of young dogs; caused by a papillomavirus. (05 Mar 2000) |
| magnesia and alumina oral suspension | A mixture of magnesium hydroxide and variable amounts of aluminum oxide; used as an antacid. (05 Mar 2000) |
| pathology, oral | A dental specialty concerned with pathology of the oral cavity. (12 Dec 1998) |
| pharyngo-oral | Relating to the pharynx and the mouth; oropharyngeal. Origin: pharyngo-+ L. Os (or-), mouth (05 Mar 2000) |
| combination oral contraceptive | A mixture of a steroid having progestational activity and an oestrogen. (05 Mar 2000) |
| contraceptives, oral | Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally oestrogen or progesterone or both. (12 Dec 1998) |
| contraceptives, oral, combined | Fixed drug combinations administered orally for contraceptive purposes. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|